Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers

被引：0
|
作者：
Lee, Jaeyop [1 ]
Ku, Geoffrey [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Gastrointestinal Oncol Serv, New York, NY 10065 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2024年 / 38卷 / 03期
关键词：
HER2; Esophagogastric cancer; Trastuzumab; Antibody drug conjugate; Immune modulation; Immunotherapy; Targeted therapy; ANTIBODY-DRUG CONJUGATE; GASTROESOPHAGEAL JUNCTION CANCER; GASTRIC-CANCER; TRASTUZUMAB DERUXTECAN; ADVANCED BREAST; HER2; STATUS; SINGLE-ARM; OPEN-LABEL; LAPATINIB; COMBINATION;
D O I：
10.1016/j.hoc.2024.02.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：585 / 598
页数：14
相关论文
共 50 条
  • [11] Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer
    Lima Jr, Nildevande F.
    Sampaio, Luana A. F.
    Xavier, Camila B.
    Mattedi, Romulo L.
    Queiroz, Marcelo A.
    Nahas, Willian C.
    Jardim, Denis L.
    JCO PRECISION ONCOLOGY, 2023, 7
  • [12] Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression
    Tozbikian, Gary
    Krishnamurthy, Savitri
    Bui, Marilyn M.
    Feldman, Michael
    Hicks, David G.
    Jaffer, Shabnam
    Khoury, Thaer
    Wei, Shi
    Wen, Hannah
    Pohlmann, Paula
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (02) : 242 - 255
  • [13] Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease
    Watanabe, Satomi
    Takeda, Masayuki
    Takahama, Takayuki
    Iwasa, Tsutomu
    Tsurutani, Junji
    Tanizaki, Junko
    Shimizu, Toshio
    Sakai, Kazuko
    Wada, Yoshitaka
    Isogai, Noritaka
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2016, 34 (03) : 394 - 396
  • [14] Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget’s disease
    Satomi Watanabe
    Masayuki Takeda
    Takayuki Takahama
    Tsutomu Iwasa
    Junji Tsurutani
    Junko Tanizaki
    Toshio Shimizu
    Kazuko Sakai
    Yoshitaka Wada
    Noritaka Isogai
    Kazuto Nishio
    Kazuhiko Nakagawa
    Investigational New Drugs, 2016, 34 : 394 - 396
  • [15] Disparities in Use of Human Epidermal Growth Hormone Receptor 2-Targeted Therapy for Early-Stage Breast Cancer
    Reeder-Hayes, Katherine
    Hinton, Sharon Peacock
    Meng, Ke
    Carey, Lisa A.
    Dusetzina, Stacie B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (17) : 2003 - +
  • [16] Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1
    Jeffrey A Kern
    Robert Wakita
    Mark X Sliwkowski
    Cancer Gene Therapy, 1999, 6 : 537 - 545
  • [17] Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1
    Kern, JA
    Wakita, R
    Sliwkowski, MX
    CANCER GENE THERAPY, 1999, 6 (06) : 537 - 545
  • [18] Epidermal growth factor receptor and human epidermal growth receptor 2 expression in parotid mucoepidermoid carcinoma: Possible implications for targeted therapy
    Shang, Jinbiao
    Shui, Yongjie
    Sheng, Liming
    Wang, Kejing
    Hu, Qiongge
    Wei, Qichun
    ONCOLOGY REPORTS, 2008, 19 (02) : 435 - 440
  • [19] Epidermal growth factor receptor-targeted therapy
    West, C. M.
    Joseph, L.
    Bhana, S.
    BRITISH JOURNAL OF RADIOLOGY, 2008, 81 : S36 - S44
  • [20] Advances in targeting human epidermal growth factor receptor-2 signaling for cancer therapy
    Meric-Bernstam, Funda
    Hung, Mien-Chie
    CLINICAL CANCER RESEARCH, 2006, 12 (21) : 6326 - 6330
12345